Benefit of 5-FU and leucovorin in stage II and III colon cancer is durable - Comment Journal Article
| Author: | Lichtman, S. M. |
| Article Title: | Benefit of 5-FU and leucovorin in stage II and III colon cancer is durable - Comment |
| Keywords: | cancer survival; clinical trial; neutropenia; fluorouracil; risk benefit analysis; note; cancer adjuvant therapy; postoperative care; cancer staging; lymph node metastasis; vincristine; prediction; folinic acid; colon cancer; colon resection; outcomes research; semustine |
| Journal Title: | The Oncology Report |
| Issue: | Fall |
| ISSN: | 1548-5323 |
| Publisher: | International Medical News Group LLC |
| Date Published: | 2005-09-01 |
| Start Page: | 49 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 24 October 2012" - "Source: Scopus" |
MSK Authors
-
228Lichtman